President Joe Biden once again used the Defense Production Act (DPA), a law established in 1950 to give the president authority over domestic industries necessary for the national defense thanks to demands caused by the Korean War, in late November, this time to invest $35 million in domestic manufacturing on medicine components to address shortages, according to a statement from the White House.